{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-027148","form_type":"8-K","ticker":"BAX","cik":"0000010456","company_name":"BAXTER INTERNATIONAL INC","filed_at":"2022-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.393524+00:00","generated_at":"2026-06-22T23:17:29.733059+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Baxter reports Q3 GAAP loss of $5.83/share on $3.1B Hillrom impairment; adjusted EPS $0.82","bullets":["Revenue $3.8B, up 17% reported, 23% constant currency, slightly positive operationally.","GAAP net loss $2.9B ($5.83/share) driven by $3.1B pre-tax impairment of Hillrom goodwill and intangibles.","Adjusted EPS $0.82, down 20% YoY; full-year adjusted EPS guidance set at $3.53 to $3.60.","U.S. sales $1.8B (+40% reported, -1% operational); International $1.9B (+1% reported, +2% operational).","FDA classified Ahmedabad manufacturing site as VAI (compliant), enabling new drug product approvals."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-027148","json":"https://secwatch.observer/filing/0001628280-22-027148.json","markdown":"https://secwatch.observer/filing/0001628280-22-027148.md","text":"https://secwatch.observer/filing/0001628280-22-027148.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/10456/000162828022027148/0001628280-22-027148-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/10456/000162828022027148/bax-20221027.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T23:17:29.733059+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e8e91f0314ebd81862125e24c1a693e91a204d73","claim":"BAXTER INTERNATIONAL INC reported third quarter of 2022 results: revenue $3.8 billion, net income ($2.9 billion), EPS ($5.83).","evidence_excerpt":"attachments, is furnished as Exhibit 99.1 to this report. --- EX-99.1 (EX-99.1) --- FOR IMMEDIATE RELEASE BAXTER REPORTS THIRD-QUARTER 2022 RESULTS • Third-quarter revenue of $3.8 billion increased 17% on a reported basis, 23% on a constant currency basis and rose slightly on an operational basis 1 • Third-quarter U.S. GAAP earnings (loss) per share (EPS) were","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/10456/000162828022027148/0001628280-22-027148-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter of 2022"},{"label":"Revenue","value":"$3.8 billion"},{"label":"Net income","value":"($2.9 billion)"},{"label":"EPS","value":"($5.83)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}